Page 100 - RaRió 9
P. 100

mayo-agosto  -  2020  /  3(9)
                                                        I   100   I




















            BioRender. (2020).  COVID-19 vaccine & therapeutics tracker. Recuperado de www.biorender.
                   com/covid-vaccine-tracker

            CDC. (2020). Interim Guidelines for collecting, handling, and testing clinical specimens for
                   COVID-19. Recuperado de https://www.cdc.gov/coronavirus/2019-nCoV/lab/guide-
                   lines-clinical-specimens.html

            Colavita, F., Lapa, D., Carletti, F., Lalle, E., Bordi, L., Marsella, P., Castilletti C. et al. (2020). SARS-
                   CoV-2 Isolation from ocular secretions of a patient with COVID-19 in Italy with prolonged vi-
                   ral RNA detection. Annals of Internal Medicine, 172(9), M20-1176. doi: 10.7326/M20-1176
            Coronaviridae Study Group of the International Committee on Taxonomy of Viruses (CSG-
                   ICTV). (2020). The species Severe acute respiratory syndrome-related coronavirus: clas-
                   sifying 2019-nCoV and naming it SARS-CoV-2. Nature Microbiology, 5(4), 536–544. doi:
                   10.1038/s41564-020-0695-z

            Foundation for Innovative New Diagnostics. (2020). SARS-CoV-2 diagnostic pipeline. Recupera-
                   do de: https://www.finddx.org/covid-19/pipeline/?section=show-all#diag_tab

            Guan, W. J., Ni, Z. Y., Hu, Y., Liang, W. H., Ou, C. Q., He, J. X., Zhong, N. S. et al. (2020). Clinical
                   characteristics of coronavirus disease 2019 in China. The New England Journal of Medi-
                   cine, 382(18), 1708-1720. doi: 10.1056/NEJMoa2002032

            InDRE. (2020). Listado de pruebas moleculares útiles para el diagnóstico de SARS-CoV-2 durante la
                   contingencia de COVID-19 en México (actualizado al 7 de mayo de 2020). Recuperado
                   de https://www.gob.mx/salud/acciones-y-programas/instituto-de-diagnostico-y-referen-
                   cia-epidemiologicos-indre

            Krüttgen, A., Cornelissen, C. G., Dreher, M., Hornef, M., Imöhl, M., & Kleines, M. (2020). Com-
                   parison of four new commercial serologic assays for determination of SARS-CoV-2 IgG.
                   Journal of Clinical Virology, 128. doi: 10.1016 / j.jcv.2020.104394

            Li, X., Geng, M., Peng, Y., Meng, L., & Lu, S. (2020). Molecular immune pathogenesis and diag-
                   nosis of COVID-19. Journal of Pharmaceutical Analysis, 10(2), 102-108. doi: 10.1016/j.
                   jpha.2020.03.001

            Loeffelholz, M. J., & Tang, Y. W. (2020). Laboratory diagnosis of emerging human coronavirus
                   infections-the state of the art. Emerging Microbes & Infections, 9, 1-26. doi: 10.1080 /
                   22221751.2020.1745095

            Cómo detectar SARS-CoV-2
            empleando pruebas de laboratorio
            De la luz, Gómez,Tufiño-Zapata, Chávez, Barba & Rivera
   95   96   97   98   99   100   101   102   103   104   105